In preclinical and in-vitro studies, this combination is being researched because the two peptides act through different endogenous receptor pathways
What are the risks and benefits
McCall McPhereson: I think a couple things
- Track side effects and patterns Log nausea, fatigue, appetite changes, and more
The Potential ROI for Covering GLP-1s, Workspan Daily Plus+ article Beyond the Rx: Maximizing GLP-1 Value Through Employee Support, Workspan Daily Plus+ article A Prescription for Rising Drug Costs, Workspan Magazine article For Everyone What Does the Data Show on GLP-1 Prescribe Rates, Coverage, Costs
While interactions between semaglutide and stimulants such as lisdexamfetamine (Vyvanse) are not well-documented, caution is warranted due to potential unforeseen interactions